Pharmacists in Neenah, Wisconsin


45 Pharmacists found in Neenah
female pharmacist

Mrs. Laura M Wallander, PHARMD


Pharmacist
1191 Westowne Dr, Neenah, WI 54956
920-725-3152     920-725-3238

female pharmacist

Lauren J Houle, PHARMD


Pharmacist
500 S Commercial St, Neenah, WI 54956
920-729-1311    

female pharmacist

Lindsey Burmeister, PHARMD


Pharmacist
1191 Westowne Dr, Neenah, WI 54956
920-725-3152    



male pharmacist

Matthew Bougie


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
130 2nd St, Neenah, WI 54956
920-725-2070    

male pharmacist

Dr. Matthew Trantow, PHARMD


Pharmacist
1155 W Winneconne Ave, Neenah, WI 54956
920-722-1185    

male pharmacist

Maxwell Tod Fredrich, PHARMD



1191 Westowne Dr, Neenah, WI 54956
920-725-3152    

female pharmacist

Mckenna Brust, PHARMD


Pharmacist
1415 S Commercial St, Neenah, WI 54956
920-729-4910    

male pharmacist

Richard Anthony Mauthe, RPH


Pharmacist
5401 W. Integrity Way, Neenah, WI 54913
920-363-7010     920-363-7001

male pharmacist

Robert Schumacher


Pharmacist
130 2nd St, Neenah, WI 54956
920-454-5880    

female pharmacist

Sara Lynn Peterson, PHARM D


Pharmacist
1554 S Commercial St, Neenah, WI 54956
920-727-3840    

female pharmacist

Sarah J Wilczek, PHARMD


Pharmacist - Pharmacotherapy
699 S Green Bay Rd, Neenah, WI 54956
920-751-0270     920-751-0267

female pharmacist

Mrs. Veronica Ann Tennie, PHARMACIST


Pharmacist
1191 Westowne Dr, Neenah, WI 54956
920-725-3152     920-722-3197

female pharmacist

Wendy M Biese, PHARMD


Pharmacist
130 2nd St, Neenah, WI 54956
612-387-2872    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.